About IXC
Invex Therapeutics (IXC) is repurposing the approved drug Exenatide — trademarked Presendin — to treat neurological conditions linked to raised intracranial pressure.
All News for IXC
No news articles found for IXC yet.
IXC
Health Care Sector News